GENOME EDITING OR GENOME ENGINEERING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-98703 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Genome Editing or Genome Engineering Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET
7.1 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA GENOME EDITING OR GENOME ENGINEERING MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Horizon Discovery Group Plc (UK)
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Thermo Fisher Scientific Inc (US)
16.3 Transposagen Biopharmaceuticals Inc (US)
16.4 Sangamo Biosciences Inc (US)
16.5 Lonza Group Ltd (Switzerland)
16.6 Merck KGAA (Germany)
16.7 New England Biolabs Inc (US)
16.8 Integrated DNA Technologies Inc (US)
16.9 Genscript Biotech Corporation (US)
16.10 Origene Technologies Inc (US)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeCRISPR
TALEN
ZFN
Antisense
Other Technologies
By Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other Applications
Companies
Horizon Discovery Group Plc (UK)
Thermo Fisher Scientific Inc (US)
Transposagen Biopharmaceuticals Inc (US)
Sangamo Biosciences Inc (US)
Lonza Group Ltd (Switzerland)
Merck KGAA (Germany)
New England Biolabs Inc (US)
Integrated DNA Technologies Inc (US)
Genscript Biotech Corporation (US)
Origene Technologies Inc (US)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.